Literature DB >> 25004891

Hippocampal degeneration in patients with amyotrophic lateral sclerosis.

Susanne Abdulla1, Judith Machts2, Jörn Kaufmann3, Karina Patrick3, Katja Kollewe4, Reinhard Dengler4, Hans-Jochen Heinze5, Susanne Petri4, Stefan Vielhaber6, Peter J Nestor2.   

Abstract

There is increasing appreciation of non-motor system involvement in amyotrophic lateral sclerosis (ALS), although its full extent and clinical significance remains to be established. This study tested the hypothesis that memory impairment in patients with ALS is related to hippocampal degeneration. Consecutive patients with ALS (58) and 29 matched controls participated in standardized neuropsychological assessment and magnetic resonance imaging. Patients with ALS performed worse in global cognitive functioning and executive and verbal memory tests (p < 0.05). The hippocampus was manually segmented in each hemisphere, and volumes were calculated with correction for intracranial volume. Analysis of covariance, controlled for the effect of age and education years, showed significantly smaller hippocampal volume on the right (p = 0.004) in patients with ALS. Verbal memory test performance correlated with the left hippocampal volume in patients with ALS (p < 0.05), although there was no significant correlation with tests of executive function and clinical variables underscoring the specificity of the present findings. Hippocampal volume loss and its correlation with the severity of verbal memory impairment highlight significant hippocampal involvement which can occur as a non-motor deficit in patients with ALS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; Frontotemporal dementia; Hippocampus atrophy; Hippocampus volumetry; Magnetic resonance imaging; Manual segmentation; Neuropsychology; Verbal memory impairment

Mesh:

Year:  2014        PMID: 25004891     DOI: 10.1016/j.neurobiolaging.2014.05.035

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment.

Authors:  Francesca Trojsi; Federica Di Nardo; Giuseppina Caiazzo; Mattia Siciliano; Giulia D'Alvano; Teresa Ferrantino; Carla Passaniti; Dario Ricciardi; Sabrina Esposito; Luigi Lavorgna; Antonio Russo; Simona Bonavita; Mario Cirillo; Gabriella Santangelo; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  Brain Imaging Behav       Date:  2020-10-23       Impact factor: 3.978

2.  Impact of neurodegenerative diseases on human adult hippocampal neurogenesis.

Authors:  J Terreros-Roncal; E P Moreno-Jiménez; M Flor-García; C B Rodríguez-Moreno; M F Trinchero; F Cafini; A Rábano; M Llorens-Martín
Journal:  Science       Date:  2021-10-21       Impact factor: 63.714

3.  Papez Circuit Gray Matter and Episodic Memory in Amyotrophic Lateral Sclerosis and Behavioural Variant Frontotemporal Dementia.

Authors:  Ana Paula Arantes Bueno; Leonardo Cruz de Souza; Walter Hugo Lopez Pinaya; Antônio Lúcio Teixeira; Laura Godoy Rousseff de Prado; Paulo Caramelli; Michael Hornberger; João Ricardo Sato
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

4.  Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).

Authors:  Sneha Chenji; Abdullah Ishaque; Dennell Mah; Esther Fujiwara; Christian Beaulieu; Peter Seres; Simon J Graham; Richard Frayne; Lorne Zinman; Angela Genge; Lawrence Korngut; Wendy Johnston; Sanjay Kalra
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

5.  Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice.

Authors:  Eros Quarta; Gianluca Fulgenzi; Riccardo Bravi; Erez James Cohen; Sudhirkumar Yanpallewar; Lino Tessarollo; Diego Minciacchi
Journal:  Mol Cell Neurosci       Date:  2018-03-24       Impact factor: 4.314

6.  Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen.

Authors:  Emma Beeldman; Rosanne Govaarts; Marianne de Visser; Michael A van Es; Yolande A L Pijnenburg; Ben A Schmand; Joost Raaphorst
Journal:  J Neurol       Date:  2021-02-06       Impact factor: 4.849

7.  Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.

Authors:  Ulises Gómez-Pinedo; Rocio N Villar-Quiles; Lucia Galán; Jordi A Matías-Guiu; Maria S Benito-Martin; Antonio Guerrero-Sola; Teresa Moreno-Ramos; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2016-11-08       Impact factor: 4.003

8.  Theory of Mind and Its Neuropsychological and Quality of Life Correlates in the Early Stages of Amyotrophic Lateral Sclerosis.

Authors:  Francesca Trojsi; Mattia Siciliano; Antonio Russo; Carla Passaniti; Cinzia Femiano; Teresa Ferrantino; Stefania De Liguoro; Luigi Lavorgna; Maria R Monsurrò; Gioacchino Tedeschi; Gabriella Santangelo
Journal:  Front Psychol       Date:  2016-12-12

9.  Cerebral Degeneration in Amyotrophic Lateral Sclerosis Revealed by 3-Dimensional Texture Analysis.

Authors:  Rouzbeh Maani; Yee-Hong Yang; Derek Emery; Sanjay Kalra
Journal:  Front Neurosci       Date:  2016-03-30       Impact factor: 4.677

Review 10.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Authors:  G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos
Journal:  BMC Neurol       Date:  2016-08-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.